Related Experiment Video
Updated: Aug 25, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
Thalidomide as a nitric oxide synthase inhibitor and its structural development
Rumiko Shimazawa1, Hiroko Sano, Aya Tanatani
1Institute of Molecular & Cellular Biosciences, The University of Tokyo, Japan. shimazaw@nihs.go.jp
Abstract:
Thalidomide has been found to exhibit weak nitric oxide synthase (NOS)-inhibitory activity. Structural development studies of thalidomide showed that some N-2,6-dimethylphenylhomophthalimide analogs possess NOS-inhibiting activity.
Related Concept Videos
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Teratogenicity
Antihypertensive Drugs: Vasodilators
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Antihypertensive Drugs: Thiazide-Class Diuretics
